

<!-- page 1 -->

w;s úfYI
wxl 2271$23 - 2022 ud¾;= ui 15 jeks wÕyrejdod - 2022'03'15
No. 2271/23  -  tuesday,  March  15 ,  2022
EXTRAORDINARY
Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha .eiÜ m;%h
The Gazette of the Democratic Socialist Republic of Sri Lanka
(Published by Authority)
PART I : SECTION (I) — GENERAL
Government Notifications
1a- G 36378 - 15 (03/2022) 
This Gazette Extraordinary can be downloaded from www.documents.gov.lk
                  
       
              
               
            
        
                  
     
         
             
         
               
            
               
               
            
               
        
                 
        
              
               
            
         
                  
 L.d.B 9/2016 (II)
THE  NATIONAL  MEDICINES  REGULATORY  AUTHORITY  ACT,  No.  5  OF  2015
REGULATIONS made by the Minister of health under section 142 of the National Medicines regulatory authority act, 
No. 5 of 2015.
Dr. Keheliya Rambukwella,
    Minister of health.
colombo,
15th March 2022.
Regulations
the Medicines (ceiling on Prices) regulations, 2019 published in the Gazette extraordinary No. 2123/35 of May 15, 2019, as 
amended by regulations published in Gazette extraordinary No. 2241/43 of august 19, 2021 are hereby amended as follows: -
(1)  by the repeal of regulation 1 thereof and the substitution therefor, of the following: -
 “1. these regulations may be cited as the Medicines (ceiling on Prices) regulations, 2019.”;

<!-- page 2 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'15
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 15.03.2022
2a
(2)  by the repeal of regulation 2 thereof and the substitution therefor, of the following: -
“2. The maximum retail price of the medicines in generic name specified in Column II of the Schedule hereto 
(hereinafter referred to as the “Scheduled Medicines”) in the dosage form or route of administration specified 
in the corresponding entry in Column III thereof of the strength specified in the corresponding entry in Column 
IV thereof shall be as specified in corresponding entry in Column V of the Schedule hereto.”;
(3)  by the repeal of regulation 3 thereof and the substitution therefor, of the following: -
“3. the maximum retail price of the scheduled Medicines shall be applicable to all the brand names of the generic 
name of such scheduled Medicines.”;
(4)  by the repeal of regulation 4 thereof and the substitution therefor, of the following: -
“4. a manufacturer, importer, trader, distributor, pharmacist, medical practitioner, dentist, veterinary surgeon, medical 
institution including a private medical institution, pharmacy or person who or which is in possession of the 
scheduled Medicines, for the purpose of sale shall not sell such scheduled Medicines above the maximum 
retail price specified in Column V of the Schedule or revised retail price as may be determined in accordance 
with the provisions of regulation 6.”;
(5)  by the repeal of regulation 6 thereof and the substitution therefor, of the following: -
“6. (1) On the date of publication of these regulations, a manufacturer or importer who sells any scheduled Medicine 
except paracetamol at a revised retail price under the Medicines (ceiling on Prices) regulations of 2019 published in 
Gazette extraordinary No. 2123/35 of May 15, 2019 as amended by the regulations published in Gazette extraordinary 
No. 2241/43 of August 19, 2021 which is less than the maximum retail price specified in Column V of the Schedule to 
the Medicines (ceiling on Prices) regulations of 2019 published in Gazette extraordinary No. 2123/35 of May 15, 2019 
may increase proportionately such revised retail price by a total thirty-eight per centum (38%). the total increase of thirty-
eight per centum (38%) includes the nine per centum (9%) increased by regulations published in Gazette extraordinary 
No. 2241/43 of august 19, 2021 and the other twenty-nine per centum (29%) increased by these regulations. 
(2) (a) On the date of publication of these regulations, a manufacturer or importer who sells a paracetamol at a revised 
retail price under the Medicines (Pricing of Paracetamol tablets/capsules 500mg) regulations, 2022 published in Gazette 
Extraordinary No. 2269/11 of February 28, 2022 which is less than the maximum retail price specified in Column V 
of the schedule hereto may increase proportionately such revised retail price by a total twenty-nine per centum (29%). 
(b) For the avoidance of doubt, it is hereby declared that the total increase of thirty-five per centum (35%) by the 
Medicines (Pricing of Paracetamol tablets/capsules 500mg) regulations, 2022 published in Gazette extraordinary No. 
2269/11 of February 28, 2022 included the increase of nine per centum (9%) of the paracetamol increased by regulations 
published in Gazette extraordinary No. 2241/43 of august 19, 2021. 
(3) Notwithstanding the provisions of sub-regulations (1) and (2), such increase of revised retail price of the scheduled 
Medicines shall not exceed the maximum retail price specified in Column V of the Schedule hereto.
(4) every trader, distributor, pharmacist, medical practitioner, dentist, veterinary surgeon, medical institution 
including a private medical institution, pharmacy or person who or which is in possession of the scheduled Medicines 
the purpose of sale shall maintain the price of the scheduled Medicines at the maximum retail price or revised retail 
price whichever is less.”;

<!-- page 3 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'15
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 15.03.2022
3a
6. by the repeal of regulation 7 thereof and the substitution therefor, of the following: -
“7. Where any dosage form or strength of the scheduled Medicines and the maximum retail price of such dosage 
form or strength of Scheduled Medicines are not specified in Column V of the Schedule hereto, the National Medicines 
Regulatory Authority shall fix the price for the Scheduled Medicines in such dosage form or strength.”;
7. by the repeal of regulation 8 thereof and the substitution therefor, of the following: -
“8. any manufacturer or importer shall print or mark on the commercial package or label of the scheduled Medicines 
the maximum retail price specified in Column V of the Schedule hereto,  or the revised retail price, whichever is less, in 
the stock manufactured or available in the market as expeditiously as possible:
Provided however, the maximum retail price or the revised retail price whichever is less shall be printed or marked 
in the commercial package or label of the Schedule Medicines before the expiry of a period of forty-five days from the 
date of publication of these regulations.”;
8. by the repeal of regulation 9 thereof :-
9. by the repeal of regulation 10 thereof and the substitution therefor, of the following: -
“10. Any person who contravenes the provisions of these regulations commits an offence and shall be triable under 
section 131 of the National Medicines regulatory authority act, No. 5 of 2015.
10. by the repeal of regulation 11 thereof and the substitution therefor, of the following: -
“11. It shall be the duty of every manufacturer, importer, trader, distributor, pharmacist, medical practitioner, dentist, 
veterinary surgeon, medical institution including a private medical institution, pharmacy or person who or which is 
in possession of the scheduled Medicines for the purpose of sale, to display at every retail outlet the maximum retail 
price of the scheduled Medicines or the revised retail price whichever is less.”;
11. by the insertion of definition for the term of expression “person”, immediately after definition of “medical practitioner”
“person” includes any body of persons corporate or unincorporate;”; and 
12.  by the repeal of the schedule and the substitution therefor, of the following: -
“ SCHEDULE 
[Regulation 2] 
MAXIMUM  RETAIL  PRICES  OF  MEDICINE 
Column I Column II 
Generic Name 
Column III 
Route of  
Administration/ 
Dosage forms 
Column IV 
Strength 
Column V 
Maximum  Retail 
Price Per unit  
(SLR) 
1 aLBeNdaZOLe tablet/ capsule 400mg 50.67 
     
2 
 
aMOXIcILLIN+cLaVuLaNIc acId Oral suspension 156mg/ 5ml 485.59 
 aMOXIcILLIN+cLaVuLaNIc acId tablet/ capsule 375mg 59.79 

<!-- page 4 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'15
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 15.03.2022
4a
Column I Column II 
Generic Name 
Column III 
Route of  
Administration/ 
Dosage forms 
Column IV 
Strength 
Column V 
Maximum  Retail 
Price Per unit  
(SLR) 
 aMOXIcILLIN+cLaVuLaNIc acId tablet/ capsule 625mg 101.33
aMOXIcILLIN+cLaVuLaNIc acId Injection 1.2g 1065.76
    
3 cLarIthrOMycIN tablet/ capsule 250mg 61.65
 cLarIthrOMycIN tablet/ capsule 500mg 124.99
cLarIthrOMycIN Oral suspension 125mg/5ml 736.40
    
4 aZIthrOMycIN tablet/ capsule 250 mg 63.51
 aZIthrOMycIN tablet/ capsule 500 mg 89.10
aZIthrOMycIN Oral suspension 200mg/ 5ml 295.56
    
5 ceFurOXIMe tablet/ capsule 250 mg 76.85
ceFurOXIMe tablet/ capsule 500 mg 122.61
    
6 dOXycycLIN tablet/ capsule 100 mg 17.07
    
7 acIcLOVIr tablet/ capsule 200 mg 62.47
    
8 cIPrOFLOXacIN tablet/ capsule 250 mg 9.71
cIPrOFLOXacIN tablet/ capsule 500 mg 14.36
    
9 LeVOFLOXacIN tablet/ capsule 250 mg 40.87
LeVOFLOXacIN tablet/ capsule 500 mg 67.56
    
10 cePhaLeXIN tablet/ capsule 250 mg 13.84
 cePhaLeXIN tablet/ capsule 500 mg 25.35
cePhaLeXIN Oral suspension 125 mg/5 ml 447.58
    

<!-- page 5 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'15
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 15.03.2022
5a
Column I Column II 
Generic Name 
Column III 
Route of  
Administration/ 
Dosage forms 
Column IV 
Strength 
Column V 
Maximum  Retail 
Price Per unit  
(SLR) 
11 ceFIXIMe tablet/ capsule 100 mg 38.84
 ceFIXIMe tablet/ capsule 200 mg 72.12
ceFIXIMe Oral suspension 100 mg/5 ml 582.69
    
12 aMLOdIPINe tablet/ capsule 5 mg 25.84
aMLOdIPINe tablet/ capsule 10 mg 35.98
    
13 dILtIaZeM tablet/ capsule 30 mg 4.57
 dILtIaZeM tablet/ capsule 60 mg 15.04
dILtIaZeM tablet/ capsule 90 mg 36.15
    
14 LOsartaN POtassIuM tablet/ capsule 25 mg 12.41
LOsartaN POtassIuM tablet/ capsule 50 mg 17.40
15 LOsartaN + hydrochlorothiazide tablet/ capsule 62.5 mg 32.84
    
16 eNaLaPrIL tablet/ capsule 5 mg 10.13
eNaLaPrIL tablet/ capsule 10 mg 17.07
    
17 ateNOLOL tablet/ capsule 25mg 5.06
 ateNOLOL tablet/ capsule 50 mg 7.43
ateNOLOL tablet/ capsule 100 mg 21.96
    
18 NIFedIPINe – sustained release tablet/ capsule 20 mg 6.26
    
19 cLOPIdOGreL tablet/ capsule 75 mg 29.57
     
20 atOrVastatIN tablet/ capsule 5mg 10.85
 atOrVastatIN tablet/ capsule 10 mg 18.83

<!-- page 6 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'15
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 15.03.2022
6a
Column I Column II 
Generic Name 
Column III 
Route of  
Administration/ 
Dosage forms 
Column IV 
Strength 
Column V 
Maximum  Retail 
Price Per unit  
(SLR) 
atOrVastatIN tablet/ capsule 20 mg 29.72
 atOrVastatIN tablet/ capsule 40 mg 41.81
    
21 rOsuVastatIN tablet/ capsule 5 mg 36.31
rOsuVastatIN tablet/ capsule 10 mg 62.47
    
22 teLMIsartaN tablet/ capsule 20 mg 17.22
 teLMIsartaN tablet/ capsule 40 mg 27.36
teLMIsartaN tablet/ capsule 80mg 51.34
    
23 asPIrIN tablet/ capsule 75 mg 5.06
asPIrIN tablet/ capsule 100 mg 8.95
    
24 MetFOrMIN tablet/ capsule 500 mg 6.67
 MetFOrMIN-sustained release tablet/ capsule 500 mg 13.00
MetFOrMIN tablet/ capsule 850 mg 12.50
    
25 GLIBeNcLaMIde tablet/ capsule 5 mg 3.70
    
26 GLIcLaZIde tablet/ capsule 80mg 19.09
    
27 thyrOXINe tablet/ capsule 50 mcg 10.29
thyrOXINe tablet/ capsule 100 mcg 15.38
    
28 GLIPIZIde tablet/ capsule 5 mg 13.35
    
29 IBuPrOFeN tablet/ capsule 200 mg 1.86
IBuPrOFeN tablet/ capsule 400mg 6.26

<!-- page 7 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'15
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 15.03.2022
7a
Column I Column II 
Generic Name 
Column III 
Route of  
Administration/ 
Dosage forms 
Column IV 
Strength 
Column V 
Maximum  Retail 
Price Per unit  
(SLR) 
    
30 dIcLOFeNac sOdIuM tablet/ capsule 50 mg 21.96
dIcLOFeNac sOdIuM tablet/ capsule 100 mg 25.50
    
31 dIcLOFeNac POtassIuM tablet/ capsule 50 mg 18.50
    
32 ParacetaMOL tablet/ capsule 500 mg 2.97
33 sOdIuM VaLPrOate tablet/ capsule 200 mg 15.20
    
34 rIsPerIdONe tablet/ capsule 1 mg 13.35
rIsPerIdONe tablet/ capsule 2 mg 15.61
    
35 OLaNZaPINe tablet/ capsule 5 mg 16.89
OLaNZaPINe tablet/ capsule 10 mg 35.11
    
36 carBaMaZePINe tablet/ capsule 200 mg 20.25
    
37 aLPraZOLaM tablet/ capsule 0.25 mg 10.98
aLPraZOLaM tablet/ capsule 0.5 mg 16.73
    
38 FLuOXetINe tablet/ capsule 20 mg 18.58
    
39 GaBaPeNtIN tablet/ capsule 100 mg 28.29
GaBaPeNtIN tablet/ capsule 300 mg 55.99
    
40 
 
BecLOMethasONe dP capsule 
(inhalation) 
200 mcg 10.13

<!-- page 8 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'15
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 15.03.2022
8a
Column I Column II 
Generic Name 
Column III 
Route of  
Administration/ 
Dosage forms 
Column IV 
Strength 
Column V 
Maximum  Retail 
Price Per unit  
(SLR) 
 
BecLOMethasONe dP capsule 
(inhalation) 
400 mcg 11.48
 
BecLOMethasONe Metered dose inhaler 
(200 doses) 
100 mcg 857.17
BecLOMethasONe Metered dose inhaler 
(200 doses) 
250 mcg 947.52
    
41 
 
saLButaMOL dP capsule 
(inhalation) 
200 mcg 6.75
 
saLButaMOL dP capsule 
(inhalation) 
400 mcg 9.29
saLButaMOL Metered dose inhaler 
(200 doses) 
100 mcg 523.59
    
42 MethyL PredNIsOLONe tablet/ capsule 4 mg 20.01
MethyL PredNIsOLONe tablet/ capsule 16mg 69.25
    
43 OMePraZOLe tablet/ capsule 20 mg 7.60
    
44 PaNtOPraZOLe tablet/ capsule 20 mg 28.70
PaNtOPraZOLe tablet/ capsule 40 mg 47.28
    
45 esOMePraZOLe tablet/ capsule 20 mg 34.11
esOMePraZOLe tablet/ capsule 40 mg 64.86
    
46 dOMPerIdONe tablet/ capsule 10 mg 9.12
    
47 raBePraZOLe tablet/ capsule 10 mg 19.09
raBePraZOLe tablet/ capsule 20 mg 36.40
    
48 aLeNdrONIc acId tablet/ capsule 70 mg 171.26
    
49 ceFtaZIdIMe INJectION 500 mg 772.12

<!-- page 9 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'15
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 15.03.2022
9a
Column I Column II 
Generic Name 
Column III 
Route of  
Administration/ 
Dosage forms 
Column IV 
Strength 
Column V 
Maximum  Retail 
Price Per unit  
(SLR) 
ceFtaZIdIMe INJectION 1 g 1286.87
    
50 ceFtrIaXONe INJectION 250 mg 386.06
 ceFtrIaXONe INJectION 500 mg 723.86
ceFtrIaXONe INJectION 1 g 1126.00
    
51 ceFOtaXIMe INJectION 500 mg 361.94
ceFOtaXIMe INJectION 1 g 603.22
    
52 FLucONaZOLe tablet/ capsule 50 mg 40.21
FLucONaZOLe tablet/ capsule 150 mg 72.38
    
53 
 
INsuLIN sOLuBLe huMaN INJectION 100 Iu/1ml 
(10 ml vial) 
1930.29
 
INsuLIN sOLuBLe huMaN INJectION 100 Iu/1ml 
(3ml 
cartridge) 
965.15
 
INsuLIN  IsOPhaNe  huMaN INJectION 100 Iu/1ml 
(10ml vial) 
1930.29
 
INsuLIN  IsOPhaNe  huMaN INJectION 100 Iu/1ml 
(3ml 
cartridge) 
965.15
 
BIPhasIc IsOPhaNe 
INsuLIN (as INsuLIN 
sOLuBLe huMaN 30Iu/1ml, 
INsuLIN IsOPhaNe huMaN  70Iu /1ml) 
 
INJectION 
100 Iu/1ml 
(10 ml vial) 
1930.29
BIPhasIc IsOPhaNe 
INsuLIN (as INsuLIN  sOLuBLe 
huMaN 30Iu/1ml,  
INsuLIN IsOPhaNe huMaN 
70Iu /1ml) 
 
 
INJectION 
100 Iu/1ml 
(3 ml 
cartridge) 
965.15
    
54 GLIMePIrIde taBLet 1 mg 11.51
 GLIMePIrIde taBLet 2 mg 16.32
 GLIMePIrIde taBLet 3 mg 27.35

<!-- page 10 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'15
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 15.03.2022
10a
Column I Column II 
Generic Name 
Column III 
Route of  
Administration/ 
Dosage forms 
Column IV 
Strength 
Column V 
Maximum  Retail 
Price Per unit  
(SLR) 
GLIMePIrIde taBLet 4 mg 29.75
    
55 sItaGLIPtIN taBLet 25 mg 24.12
 sItaGLIPtIN taBLet 50 mg 45.83
sItaGLIPtIN taBLet 100 mg 78.01
    
56 taMsuLOsIN tablet/ capsule 0.40 mg 33.77
    
57  MONteLuKast taBLet 4 mg 19.31
 MONteLuKast taBLet 5 mg 24.12
MONteLuKast taBLet 10 mg 33.77
    
58 PreGaBaLIN tablet/ capsule 50 mg 19.70
 PreGaBaLIN tablet/ capsule 75 mg 24.94
 PreGaBaLIN tablet/ capsule 100 mg 30.96
 PreGaBaLIN tablet/ capsule 150 mg 38.61
PreGaBaLIN tablet/ capsule 300 mg 63.55
    
59 tOPIraMate tablet/ capsule 25 mg 32.17
 tOPIraMate tablet/ capsule 50 mg 51.47
tOPIraMate tablet/ capsule 100 mg 83.64
    
60 LaMOtrIGINe taBLet 25 mg 19.31
 LaMOtrIGINe taBLet 50 mg 33.77
LaMOtrIGINe taBLet 100 mg 56.30
13. the Medicines (Pricing of Paracetamol tablets/capsules 500mg) regulations, 2022 published in Gazette Extraordinary 
No. 2269/11 of February 28, 2022 is hereby rescinded.
eOG 03–0897
PrINted at the dePartMeNt OF GOVerNMeNt PrINtING,  srI LaNKa.